358 related articles for article (PubMed ID: 30523401)
1. Cytotoxic Natural Killer Subpopulations as a Prognostic Factor of Malignant Pleural Effusion.
Herrera Lara S; Fernández-Fabrellas E; Juan Samper G; Marco Buades J; Andreu Lapiedra R; Pinilla Moreno A; Morales Suárez-Varela M
Lung; 2019 Feb; 197(1):53-60. PubMed ID: 30523401
[TBL] [Abstract][Full Text] [Related]
2. Native soluble carcinoembryonic antigen is not involved in the impaired activity of CD56 natural killer cells in malignant pleural effusion.
Qi J; Li D; Feng J; Yang S; Su Y; Fang M; Tan Z; Shi H; Yan X; Gong F; Zheng F
Respiration; 2013; 86(3):216-23. PubMed ID: 23258197
[TBL] [Abstract][Full Text] [Related]
3. Terminal Differentiation of CD56(dim)CD16(+) Natural Killer Cells Is Associated with Increase in Natural Killer Cell Frequencies After Antiretroviral Treatment in HIV-1 Infection.
Ahmad F; Tufa DM; Mishra N; Jacobs R; Schmidt RE
AIDS Res Hum Retroviruses; 2015 Dec; 31(12):1206-12. PubMed ID: 26352913
[TBL] [Abstract][Full Text] [Related]
4. Early Cytomegalovirus Reactivation and Expansion of CD56
Jang JE; Hwang DY; Chung H; Kim SJ; Eom JI; Jeung HK; Song J; Kim JS; Cheong JW; Min YH
Biol Blood Marrow Transplant; 2019 Oct; 25(10):2070-2078. PubMed ID: 31212079
[TBL] [Abstract][Full Text] [Related]
5. Natural Killer Cells from Malignant Pleural Effusion Are Endowed with a Decidual-Like Proangiogenic Polarization.
Bosi A; Zanellato S; Bassani B; Albini A; Musco A; Cattoni M; Desio M; Nardecchia E; D'Urso DG; Imperatori A; Dominioni L; Noonan DM; Mortara L; Bruno A
J Immunol Res; 2018; 2018():2438598. PubMed ID: 29713652
[TBL] [Abstract][Full Text] [Related]
6. NK Cell Subsets Changes in Partial Remission and Early Stages of Pediatric Type 1 Diabetes.
Gomez-Muñoz L; Perna-Barrull D; Villalba A; Rodriguez-Fernandez S; Ampudia RM; Teniente-Serra A; Vazquez F; Murillo M; Perez J; Corripio R; Bel J; Vives-Pi M
Front Immunol; 2020; 11():611522. PubMed ID: 33569058
[TBL] [Abstract][Full Text] [Related]
7. Peritoneal natural killer cells from epithelial ovarian cancer patients show an altered phenotype and bind to the tumour marker MUC16 (CA125).
Belisle JA; Gubbels JA; Raphael CA; Migneault M; Rancourt C; Connor JP; Patankar MS
Immunology; 2007 Nov; 122(3):418-29. PubMed ID: 17617155
[TBL] [Abstract][Full Text] [Related]
8. Analysis of natural killer-associated antigens in peripheral blood and bone marrow of multiple myeloma patients and prognostic implications.
García-Sanz R; González M; Orfão A; Moro MJ; Hernández JM; Borrego D; Carnero M; Casanova F; Bárez A; Jiménez R; Portero JA; San Miguel JF
Br J Haematol; 1996 Apr; 93(1):81-8. PubMed ID: 8611480
[TBL] [Abstract][Full Text] [Related]
9. The unexpected effect of cyclosporin A on CD56+CD16- and CD56+CD16+ natural killer cell subpopulations.
Wang H; Grzywacz B; Sukovich D; McCullar V; Cao Q; Lee AB; Blazar BR; Cornfield DN; Miller JS; Verneris MR
Blood; 2007 Sep; 110(5):1530-9. PubMed ID: 17495133
[TBL] [Abstract][Full Text] [Related]
10. Lymphoid subsets in acute myeloid leukemias: increased number of cells with NK phenotype and normal T-cell distribution.
Vidriales MB; Orfao A; López-Berges MC; González M; Hernandez JM; Ciudad J; López A; Moro MJ; Martínez M; San Miguel JF
Ann Hematol; 1993 Nov; 67(5):217-22. PubMed ID: 7694663
[TBL] [Abstract][Full Text] [Related]
11. CD56
Vujanovic L; Chuckran C; Lin Y; Ding F; Sander CA; Santos PM; Lohr J; Mashadi-Hossein A; Warren S; White A; Huang A; Kirkwood JM; Butterfield LH
Front Immunol; 2019; 10():14. PubMed ID: 30761123
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of peripheral blood NK cell subsets and cytokines in unexplained recurrent miscarriage.
Adib Rad H; Basirat Z; Mostafazadeh A; Faramarzi M; Bijani A; Nouri HR; Soleimani Amiri S
J Chin Med Assoc; 2018 Dec; 81(12):1065-1070. PubMed ID: 30145058
[TBL] [Abstract][Full Text] [Related]
13. Specific phenotype and function of CD56-expressing innate immune cell subsets in human thymus.
Gerstner S; Köhler W; Heidkamp G; Purbojo A; Uchida S; Ekici AB; Heger L; Luetke-Eversloh M; Schubert R; Bader P; Klingebiel T; Koehl U; Mackensen A; Romagnani C; Cesnjevar R; Dudziak D; Ullrich E
J Leukoc Biol; 2016 Dec; 100(6):1297-1310. PubMed ID: 27354408
[TBL] [Abstract][Full Text] [Related]
14. CD56bright natural killer (NK) cells: an important NK cell subset.
Poli A; Michel T; Thérésine M; Andrès E; Hentges F; Zimmer J
Immunology; 2009 Apr; 126(4):458-65. PubMed ID: 19278419
[TBL] [Abstract][Full Text] [Related]
15. Predicting Malignant and Paramalignant Pleural Effusions by Combining Clinical, Radiological and Pleural Fluid Analytical Parameters.
Herrera Lara S; Fernández-Fabrellas E; Juan Samper G; Marco Buades J; Andreu Lapiedra R; Pinilla Moreno A; Morales Suárez-Varela M
Lung; 2017 Oct; 195(5):653-660. PubMed ID: 28656381
[TBL] [Abstract][Full Text] [Related]
16. Natural Killer Cells Generated From Human Induced Pluripotent Stem Cells Mature to CD56
Euchner J; Sprissler J; Cathomen T; Fürst D; Schrezenmeier H; Debatin KM; Schwarz K; Felgentreff K
Front Immunol; 2021; 12():640672. PubMed ID: 34017328
[TBL] [Abstract][Full Text] [Related]
17. A large quantity of CD3-/CD19-/CD16- lymphocytes in malignant pleural effusion from a patient with recurrent cholangio cell carcinoma.
Onishi H; Morisaki T; Kuga H; Katano M; Doi F; Uchiyama A; Sugitani A; Wada J; Chijiiwa K; Tanaka M
Immunol Invest; 2002 May; 31(2):121-35. PubMed ID: 12148948
[TBL] [Abstract][Full Text] [Related]
18. CD56brightCD16- NK Cells Produce Adenosine through a CD38-Mediated Pathway and Act as Regulatory Cells Inhibiting Autologous CD4+ T Cell Proliferation.
Morandi F; Horenstein AL; Chillemi A; Quarona V; Chiesa S; Imperatori A; Zanellato S; Mortara L; Gattorno M; Pistoia V; Malavasi F
J Immunol; 2015 Aug; 195(3):965-72. PubMed ID: 26091716
[TBL] [Abstract][Full Text] [Related]
19. CD56brightCD16- killer Ig-like receptor- NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation.
Romagnani C; Juelke K; Falco M; Morandi B; D'Agostino A; Costa R; Ratto G; Forte G; Carrega P; Lui G; Conte R; Strowig T; Moretta A; Münz C; Thiel A; Moretta L; Ferlazzo G
J Immunol; 2007 Apr; 178(8):4947-55. PubMed ID: 17404276
[TBL] [Abstract][Full Text] [Related]
20. CD56
Wang H; Zeng Y; Zhang M; Ma H; Xu B; Jiang H; Wang J; Li G
Hum Immunol; 2019 Oct; 80(10):871-877. PubMed ID: 31326139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
